AArtificial intelligence Read More Jim Cramer’s framework for identifying winners in age of AI disruptionFebruary 25, 2026 CNBC’s Jim Cramer on Tuesday outlined a simple framework to make sense of the current market, as the…
MMedication Read More FDA accepts BMS protein degrader for review; Disc rare disease drug rejectedFebruary 19, 2026 This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free…
MMedication Read More More drugs should be over-the-counterFebruary 18, 2026 Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over the counter”…
HHealth care Read More Johnson & Johnson (JNJ) Q4 earningsJanuary 21, 2026 Johnson & Johnson said on Thursday that it has reached an agreement with the U.S. President administration to…
BBusiness Read More Stock market today: Live updatesJanuary 21, 2026 Traders work on the floor at the New York Stock Exchange, Jan. 20, 2026. Michael Nagle | Bloomberg…
BBusiness Read More Stock market today: Live updatesJanuary 20, 2026 Trades work at the New York Stock Exchange on Jan. 16, 2026. NYSE Stock futures on Monday night…
HHealth care Read More I talked to many health CEOs out West and see big things for drug stocksJanuary 18, 2026 We get so caught up in the buzz and the sizzle that we forget about the steak, especially…
PPersonal finance Read More Retiring at 64 With $2.1 Million Means Navigating a $10,500 Annual Gap Nobody Talks AboutJanuary 13, 2026 JU.STOCKER / Shutterstock.com A 3.9% withdrawal rate yields $81,900 annually but dividend income only covers $73,500. Medicare Part…
HHealth care Read More The GLP-1 Blockbuster Maker Widens Its Lead as the Diversified Healthcare Giant Posts Steady GrowthJanuary 11, 2026 jetcityimage / iStock Editorial via Getty Images Lilly posted 53.9% revenue growth and 480% net income growth driven…
HHealth care Read More Johnson & Johnson announces deal to cut drug prices, new Pennsylvania manufacturing site | Berks Regional NewsJanuary 10, 2026 NEW BRUNSWICK, Nj. – Johnson & Johnson is the latest U.S. drugmaker to announce a deal with the…
HHealth care Read More Johnson & Johnson MedTech submits Ottava surgical robot to FDAJanuary 8, 2026 Johnson & Johnson MedTech (NYSE: JNJ) + announced today that it submitted its Ottava surgical robotic system to…
EEntertainment Read More What may be driving Eli Lilly shares lower — plus, oil, financial stocks rallyJanuary 5, 2026 Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…